DRAM1 and central nervous system cancer: We also looked at another important autophagy modulator, DRAM1, in our study and found its overexpression in 28.2% of the cases; it was not significantly associated with tumor grades, but higher expression of DRAM1 was present in high-grade gliomas when compared with LGGs.